Ew Healthcare Partners Fund 2, L.P. has bought TELA on 39 days since Apr 2020

EW Healthcare Partners Fund 2, L.P. is a growth equity fund managed by EW Healthcare Partners, a leading healthcare investment firm founded in 1985 with nearly $4 billion raised since inception.( The fund, raised in 2018 for over $745 million (exceeding its $650 million target), focuses on investing in fast-growing, commercial-stage healthcare companies in the US and Europe across pharmaceuticals, medical devices, diagnostics, and technology-enabled services, targeting firms with $20-200 million in revenue and ~20% annual growth potential.(

As part of EW Healthcare Partners' strategy, Fund 2 supports portfolio companies through hands-on collaboration, capital for sales expansion, geographic growth, acquisitions, and product development, backed by a team of over 20 senior professionals and advisors including former executives from Medtronic, Bristol-Myers Squibb, and others.( The firm operates from offices in Palo Alto, Houston, New York, and London, with leadership including Managing Director Petri Vainio and Co-Founder Marty Sutter.( Recently, the fund has been active as a corporate insider in trading at Tela Bio, Inc. (TELA), filing as 'See Remarks, 10%'.(

Written by Perplexity from public sources.